Global Neoantigen Cancer Vaccine Market Size By Product, By Route Of Administration, By Technology, By Application, By Geographic Scope And Forecast
Report ID: 39348|No. of Pages: 202
Global Neoantigen Cancer Vaccine Market Size By Product, By Route Of Administration, By Technology, By Application, By Geographic Scope And Forecast
Neoantigen Cancer Vaccine Market Size And Forecast
Neoantigen Cancer Vaccine Market size was valued at USD 25.4 Million in 2024 and is projected to reach USD 2,322.8 Million by 2031, growing at a CAGR of 72.6% during the forecast period 2024-2031.
Global Neoantigen Cancer Vaccine Market Drivers
The market drivers for the Neoantigen Cancer Vaccine Market can be influenced by various factors. These may include:
- Advancements in Immunotherapy: Development and success of immunotherapies have made individualised cancer medicines, such as neoantigen-based vaccinations, possible. These vaccinations are quite successful since they can target particular tumour antigens.
- Rising Cancer Incidence: A significant need for novel and efficient therapies has been generated by the growing incidence of different kinds of cancers worldwide. For many people, neoantigen cancer vaccines provide a promising answer.
- Technological Innovations: The identification and validation of neoantigens have been much enhanced by developments in sequencing technologies and bioinformatics, which has made the creation of customised vaccinations possible.
- Supportive Regulatory Environment: Neoantigen vaccines and other novel cancer therapies have received assistance from regulatory bodies including the FDA and EMA through expedited clearance processes and orphan medication designations.
- Growing Funding and Investment: Projects involving neoantigen vaccines are among the cancer research and development areas receiving growing funding from both the public and private sectors. Advancement of clinical trials and introduction of novel treatments depend on this financial support.
- Partnerships and Collaborations: The creation and release of neoantigen cancer vaccines has been expedited by cooperation among academic institutions, pharmaceutical businesses, biotech companies, and research institutes.
- Rising Interest in Neoantigen Cancer Vaccines: Neoantigen cancer vaccine interest has increased with the move in oncology towards personalised therapy, where treatments are customised to each patient depending on their genetic makeup and unique tumour features. With their very individualised approach, these vaccinations may improve patient outcomes.
- Positive Clinical Outcomes: Neoantigen cancer vaccine safety and efficacy have been demonstrated by early clinical trials and investigations. In this market, positive clinical findings motivate more study and investment.
- Government and Non-Profit Initiatives: A number of government agencies and non-profits are promoting market expansion by funding, subsidising, and raising awareness of cancer vaccine research.
- Growing Healthcare Spending: More research and development in the oncology field, including neoantigen cancer vaccines, is made possible by growing healthcare spending, especially in industrialised nations.
Global Neoantigen Cancer Vaccine Market Restraints
Several factors can act as restraints or challenges for the Neoantigen Cancer Vaccine Market. These may include:
- High Development Costs: A great deal of study and clinical testing go into the complicated and costly process of creating neoantigen cancer vaccines.
- Regulatory Difficulties: New vaccine introductions may be delayed by strict regulatory restrictions and protracted licencing procedures.
- Limited Patient Population: The market size is limited since neoantigen vaccines are highly individualised and target certain mutations in the tumours of individual patients.
- Technical Difficulties: Complex bioinformatics and genomic analysis are needed for the technically demanding identification and validation of neoantigens.
- Complexity of Manufacturing: Customised manufacturing procedures are needed for every patient in the time-consuming and complicated process of producing neoantigen vaccinations.
- Competition from Other medicines: Conventional cancer medicines include radiation and chemotherapy as well as immunotherapies and targeted therapies pose a serious threat.
- Limited Clinical Data: Because neoantigen cancer vaccines are a relatively new field of study, there aren’t much long-term clinical data to support their effectiveness and safety, which may impact market acceptance.
Global Neoantigen Cancer Vaccine Market Segmentation Analysis
The Global Neoantigen Cancer Vaccine Market is Segmented on the basis of Product, Route of Administration, Technology, Application, and Geography.
Neoantigen Cancer Vaccine Market, By Product
- Personalized Neoantigen Vaccine: Customized vaccines tailored to an individual patient’s tumor-specific neoantigens.
- Off-the-shelf Neoantigen Vaccine: Standardized vaccines targeting common neoantigens found across multiple patients.
Neoantigen Cancer Vaccine Market, By Route of Administration
- Intravenous: Direct injection of the vaccine into the bloodstream.
- Intramuscular: Vaccine injection into muscle tissue.
- Subcutaneous: Injection of the vaccine into the tissue layer between the skin and muscle.
Neoantigen Cancer Vaccine Market, By Technology
- DNA Sequencing: Techniques that sequence DNA to identify neoantigens.
- RNA Sequencing: Techniques that sequence RNA to find expressed neoantigens.
- Next Generation Sequencing: Advanced sequencing technologies offering high throughput and accuracy in neoantigen identification.
Neoantigen Cancer Vaccine Market, By Application
- Lung Cancer: Vaccines targeting neoantigens specific to lung cancer.
- Melanoma: Vaccines developed for neoantigens associated with melanoma.
- Gastrointestinal Cancer: Vaccines focusing on neoantigens found in gastrointestinal cancers.
- Head and Neck Cancer: Vaccines designed to target neoantigens in head and neck cancers.
- Others: Vaccines targeting neoantigens in various other cancer types.
Neoantigen Cancer Vaccine Market, By Geography
- North America: Market trends and dynamics in the USA, Canada, and Mexico.
- Europe: Market analysis across European countries including the UK, Germany, France, etc.
- Asia-Pacific: Market insights from countries like China, Japan, India, and others in the region.
- Latin America: Market developments in countries such as Brazil, Argentina, etc.
- Middle East & Africa: Market overview for countries in the Middle East and Africa.
Key Players
The major players in the Neoantigen Cancer Vaccine Market
- Avidea Technologies
- Agenus
- Roche
- Nouscom, Genocea Biosciences
- Gritstone Oncology
- Gilead Sciences
- BioNTech
- ISA Pharmaceutical
- Vaccibody
Report Scope:
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2021-2031 |
| BASE YEAR | 2024 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2021-2023 |
| UNIT | Value (USD Million) |
| KEY COMPANIES PROFILED | Avidea Technologies, Agenus, Roche, Nouscom, Genocea Biosciences, Gritstone Oncology, Gilead Sciences, BioNTech, ISA Pharmaceutical, and Vaccibody. |
| SEGMENTS COVERED | By Product, By Route Of Administration, By Technology, By Application, And By Geography. |
| CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL NEOANTIGEN CANCER VACCINE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NEOANTIGEN CANCER VACCINE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
5 GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY TECHNOLOGY
1. DNA Sequencing
2. RNA Sequencing
3. Next Generation Sequencing
6 GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY APPLICATION
1. Lung Cancer
2. Melanoma
4. Head and Neck Cancer
3. Gastrointestinal Cancer
5. Others
7 GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY ROUTE OF ADMINISTRATION
1. Intravenous
2. Intramuscular
3. Subcutaneous
8 GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY PRODUCT
1. Personalized Neoantigen Vaccine
2. Off-the-shelf Neoantigen Vaccine
12 GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY GEOGRAPHY
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Rest of Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Rest of Asia Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 Middle East and Africa
13 GLOBAL NEOANTIGEN CANCER VACCINE MARKET COMPETITIVE LANDSCAPE
13.1 Overview
13.2 Company Market ranking
13.3 Key Development Strategies
14 COMPANY PROFILES
14.1 Avidea Technologies
14.1.1 Overview
14.1.2 Financial Performance
14.1.3 Product Outlook
14.1.4 Key Developments
14.2 Agenus
14.2.1 Overview
14.2.2 Financial Performance
14.2.3 Product Outlook
14.2.4 Key Developments
14.3 Roche
14.3.1 Overview
14.3.2 Financial Performance
14.3.3 Product Outlook
14.3.4 Key Developments
14.4 Nouscom
14.4.1 Overview
14.4.2 Financial Performance
14.4.3 Product Outlook
14.4.4 Key Developments
14.5 Genocea Biosciences
14.5.1 Overview
14.5.2 Financial Performance
14.5.3 Product Outlook
14.5.4 Key Developments
14.6 Gritstone Oncology
14.6.1 Overview
14.6.2 Financial Performance
14.6.3 Product Outlook
14.6.4 Key Developments
14.7 Gilead Sciences
14.7.1 Overview
14.7.2 Financial Performance
14.7.3 Product Outlook
14.7.4 Key Developments
14.8 BioNTech
14.8.1 Overview
14.8.2 Financial Performance
14.8.3 Product Outlook
14.8.4 Key Developments
14.9 ISA Pharmaceutical
14.9.1 Overview
14.9.2 Financial Performance
14.9.3 Product Outlook
14.9.4 Key Developments
14.10 Vaccibody
14.10.1 Overview
14.10.2 Financial Performance
14.10.3 Product Outlook
14.10.4 Key Developments
15 APPENDIX
15.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
